Hepatitis E Diagnostic Tests companies

  • Report ID: 6507
  • Published Date: Aug 12, 2025
  • Report Format: PDF, PPT

Key Hepatitis E Diagnostic Tests Market Players:

    Numerous firms have set up initiatives to conduct diagnostic tests for hepatitis E, which is an important public health concern. Companies that deal with hepatitis E diagnostic tests vary with different approaches in conducting the test, which may include serological assays targeting antibodies and molecular tests targeting the identification of the virus's genetic material. Advances in diagnostic technology focus on increasing the efficiency, speed, and accessibility of hepatitis E testing. As awareness about the disease increases, these companies play an important role in promoting early detection and efficient management, further improving healthcare outcomes and surveillance in the infected regions. The prominent players with valuable contributions are:

    • Altona Diagnostic GmbH
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • CTK Biotech, Inc.
    • Dia.Pro Diagnostic Bioprobes s.r.l
    • DiaSorin S.p.A.
    • ELITechGroup (Bruker company)
    • F. Hoffmann-La Roche Ltd
    • Fortress Diagnostic
    • Genscript Biotech Corporation
    • Guangzhou Wondfo Biotech Co., Ltd.
    • Medsource Ozone Biomedicals Pvt. Ltd.
    • MIKROGEN GmbH
    • MP Biomedicals
    • Primer Design
    • Wantai BioPharm

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of hepatitis E diagnostic tests is evaluated at USD 69.31 million.

Hepatitis E Diagnostic Tests Market size was over USD 66.61 million in 2025 and is projected to reach USD 103.44 million by 2035, growing at around 4.5% CAGR during the forecast period i.e., between 2026-2035.

North America's 44.6% share in the Hepatitis E Diagnostic Tests Market is driven by well-developed health infrastructure, research funding, and robust regulatory frameworks, positioning it as a leader in diagnostic advancements through 2035.

Key players in the market include Fortress Diagnostic, Genscript Biotech Corporation, Guangzhou Wondfo Biotech Co., Ltd., Medsource Ozone Biomedicals Pvt. Ltd., MIKROGEN GmbH, MP Biomedicals.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos